From: Clinical characteristics of pregnant women with COVID-19 in Japan: a nationwide questionnaire survey
Symptomatic patients (n = 58) | Asymptomatic patients (n = 14) | P-value | |
---|---|---|---|
Maternal age | |||
Median (interquartile range) | 31 (27–36) | 32 (25–33) | 0.41 |
Under 20 | 0 (0%) | 0 (0%) | > 0.99 |
20–29 | 20 (34.5%) | 6 (42.9%) | 0.56 |
30–39 | 33 (56.9%) | 8 (57.1%) | 0.99 |
over 40 | 5 (8.6%) | 0 (0%) | 0.58 |
Approach for diagnosis | |||
Symptom | 57 (98.3%) | 0 (0%) | < 0.001 |
Contact with confirmed or suspected patients | 1 (1.7%) | 12 (85.7%) | < 0.001 |
Universal screening | 0 (0%) | 2 (14.3%) | 0.04 |
Pregnancy period at diagnosis | |||
1st trimester | 12 (20.7%) | 3 (21.4%) | > 0.99 |
2nd trimester | 28 (48.3%) | 4 (28.6%) | 0.18 |
3rd trimester | 15 (25.9%) | 5 (35.7%) | 0.51 |
Postpartum | 3 (5.2%) | 2 (14.3%) | 0.25 |
Epidemiological history | |||
Familial infection | 33 (56.9%) | 8 (57.1%) | 0.99 |
Community-acquired | 5 (8.6%) | 3 (21.4%) | 0.18 |
Visiting and staying in infected areas | 4 (6.9%) | 0 (0%) | 0.58 |
Nosocomial infection | 2 (3.4%) | 1 (7.1%) | 0.48 |
Workplace infection | 1 (1.7%) | 2 (14.3%) | 0.10 |
Unknown | 13 (22.4%) | 0 (0%) | 0.06 |
Comorbidities | |||
Gestational diabetes | 5 (8.6%) | 0 (0%) | 0.58 |
Preeclampsia | 1 (1.7%) | 0 (0%) | > 0.99 |
Asthma | 3 (5.2%) | 0 (0%) | > 0.99 |
Course of pregnancya | |||
Pregnancy ongoing | 29 (50.0%) | 7 (50.0%) | > 0.99 |
Delivery | 21 (36.2%) | 5 (35.7%) | 0.97 |
Delivery during infection | 9 (15.5%) | 3 (21.4%) | 0.69 |
Spontaneous abortion | 2 (3.4%) | 0 (0%) | > 0.99 |
Induced abortion | 1 (1.7%) | 0 (0%) | > 0.99 |
Prognosis of mother | |||
Recovered without subsequent complication | 57 (98.3%) | 14 (100%) | > 0.99 |
Death | 1 (1.7%) | 0 (0%) | > 0.99 |